XCRT Stock Overview
Acquires engineering/patents and applies to early-stage medical technology companies.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Xcelerate Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.022 |
| 52 Week High | US$0.14 |
| 52 Week Low | US$0.014 |
| Beta | 3.03 |
| 11 Month Change | -27.27% |
| 3 Month Change | -43.65% |
| 1 Year Change | -63.10% |
| 33 Year Change | -76.04% |
| 5 Year Change | 1,766.67% |
| Change since IPO | -96.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| XCRT | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -2.2% | -0.9% | 0.7% |
| 1Y | -63.1% | 2.4% | 23.3% |
Return vs Industry: XCRT underperformed the US Healthcare industry which returned 2.4% over the past year.
Return vs Market: XCRT underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| XCRT volatility | |
|---|---|
| XCRT Average Weekly Movement | 25.7% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: XCRT's share price has been volatile over the past 3 months.
Volatility Over Time: XCRT's weekly volatility (26%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 12 | Michael O’Shea | www.xcelerate.global |
Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types.
Xcelerate Inc. Fundamentals Summary
| XCRT fundamental statistics | |
|---|---|
| Market cap | US$9.95m |
| Earnings (TTM) | -US$2.75m |
| Revenue (TTM) | US$1.12m |
8.7x
P/S Ratio-3.5x
P/E RatioIs XCRT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XCRT income statement (TTM) | |
|---|---|
| Revenue | US$1.12m |
| Cost of Revenue | US$827.97k |
| Gross Profit | US$294.12k |
| Other Expenses | US$3.04m |
| Earnings | -US$2.75m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0063 |
| Gross Margin | 26.21% |
| Net Profit Margin | -245.14% |
| Debt/Equity Ratio | -907.2% |
How did XCRT perform over the long term?
See historical performance and comparison